(Q35970298)

11 August 2017

1 reference

title

A humanized monoclonal antibody targeting Staphylococcus aureus (English)

1 reference

11 August 2017

1 reference

Staphylococcus aureus

1 reference

1 reference

Joseph M Patti

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

11 August 2017

1 reference

11 August 2017

volume

22 Suppl 1

1 reference

11 August 2017

page(s)

S39-43

1 reference

Nosocomial infections in surgical patients in the United States, January 1986-June 1992. National Nosocomial Infections Surveillance (NNIS) System

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Reimbursement for nosocomial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Bacteriophages: potential treatment for bacterial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Development of Antistaphylococcal Vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Clumping factor A mediates binding of Staphylococcus aureus to human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Expression of Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris using a new shuttle vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Study of Staphylococcus aureus pathogenic genes by transfer and expression in the less virulent organism Streptococcus gordonii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Transcription of clumping factor A in attached and unattached Staphylococcus aureus in vitro and during device-related infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective Endocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.08.015

10.1016/J.VACCINE.2004.08.015

7 January 2021

Identifiers

DOI

0 references

Fatcat ID

release_hkrfqawiy5fm5iva3pw4szuys4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hkrfqawiy5fm5iva3pw4szuys4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference